title: A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.
abstract: A-Type lamins, arising from the LMNA gene, are intermediate filaments proteins that belong to the lamina, a ubiquitous nuclear network. Naturally occurring mutations in these proteins have been shown to be responsible for several distinct diseases that display skeletal and/or cardiac muscle or peripheral nerve involvement. These include familial partial lipodystrophy of the Dunnigan type and the mandibuloacral dysplasia syndrome. The pathophysiology of this group of diseases, often referred to as laminopathies, remains elusive. We report a new condition in a 30-yr-old man exhibiting a previously undescribed heterozygous R133L LMNA mutation. His phenotype associated generalized acquired lipoatrophy with insulin-resistant diabetes, hypertriglyceridemia, hepatic steatosis, hypertrophic cardiomyopathy with valvular involvement, and disseminated whitish papules. Immunofluorescence microscopic analysis of the patient's cultured skin fibroblasts revealed nuclear disorganization and abnormal distribution of A-type lamins, similar to that observed in patients harboring other LMNA mutations. This observation broadens the clinical spectrum of laminopathies, pointing out the clinical variability of lipodystrophy and the unreported possibility of hypertrophic cardiomyopathy and skin involvement. It emphasizes the fact that the diagnosis of genetic alterations in A-type lamins requires careful and complete clinical and morphological investigations in patients regardless of the presenting signs.
authors.affiliation: Service de Dermatologie, Hôpital Avicenne, 93000 Bobigny, France.
authors.forename: F
authors.initials: F
authors.lastname: Caux
authors.forename: E
authors.initials: E
authors.lastname: Dubosclard
authors.forename: O
authors.initials: O
authors.lastname: Lascols
authors.forename: B
authors.initials: B
authors.lastname: Buendia
authors.forename: O
authors.initials: O
authors.lastname: Chazouillères
authors.forename: A
authors.initials: A
authors.lastname: Cohen
authors.forename: J-C
authors.initials: JC
authors.lastname: Courvalin
authors.forename: L
authors.initials: L
authors.lastname: Laroche
authors.forename: J
authors.initials: J
authors.lastname: Capeau
authors.forename: C
authors.initials: C
authors.lastname: Vigouroux
authors.forename: S
authors.initials: S
authors.lastname: Christin-Maitre
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics*; D017124:Conserved Sequence; D003920:Diabetes Mellitus / Q000235:genetics*; D005234:Fatty Liver / Q000235:genetics*; D006801:Humans; D007333:Insulin Resistance; D034904:Lamin Type A / Q000737:chemistry / Q000235:genetics*; D008060:Lipodystrophy / Q000235:genetics*; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation; D012871:Skin Diseases / Q000235:genetics
chemical_list: D034904:Lamin Type A; C440308:lamin C